The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy
Research output: Contribution to journal › Letter › Research › peer-review
Original language | English |
---|---|
Journal | American Journal of Hematology |
Volume | 97 |
Issue number | 3 |
Pages (from-to) | E117-E120 |
ISSN | 0361-8609 |
DOIs | |
Publication status | Published - 2022 |
ID: 313778617